Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Head & Neck 2Thoracic 1Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Lymphoma 225Lymphoma, Large B-Cell, Diffuse 160Precursor Cell Lymphoblastic Leukemia-Lymphoma 143Lymphoma, Non-Hodgkin 139Hodgkin Disease 106Burkitt Lymphoma 99Lymphoma, Follicular 85Leukemia 82Lymphoma, Mantle-Cell 76Lymphoma, Large-Cell, Immunoblastic 68Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, B-Cell, Marginal Zone 43Leukemia, Myeloid, Acute 34Recurrence 31Lymphoma, B-Cell 31Lymphoma, Large-Cell, Anaplastic 30Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29Dendritic Cell Sarcoma, Interdigitating 29Lymphoma, Extranodal NK-T-Cell 26Multiple Myeloma 24Waldenstrom Macroglobulinemia 22Myelodysplastic Syndromes 22Lymphoma, T-Cell, Peripheral 22Lymphoma, T-Cell, Cutaneous 20Blast Crisis 19Lymphoma, T-Cell 18Leukemia, Myeloid, Accelerated Phase 18Immunoblastic Lymphadenopathy 18Congenital Abnormalities 18Neoplasms, Plasma Cell 16

Interventions

Cyclophosphamide 2tanespimycin 1entinostat 1Vorinostat 1Thiotepa 1Thalidomide 1SUB1 protein, human 1Ritonavir 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Indinavir 1Filgrastim 1Fentanyl 1Etoposide 1Docetaxel 1Cryosurgery 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esthesioneuroblastoma, Olfactory × Etoposide × Lymphoid × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡